Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma

被引:17
|
作者
Zhu, Lili [1 ]
Shen, Yiyin [1 ]
Sun, Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Stomatol, Shanghai, Peoples R China
关键词
PON3; OSCC; Cell proliferation; AP-1; IMMUNE ESCAPE; CANCER; PATHWAY;
D O I
10.1016/j.biopha.2016.11.084
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Paraoxonase 3 (PON3) is an oncogene in cancer, however, little is known about the mechanisms and roles of PON3 in oral squamous cell carcinoma (OSCC), which is the aim of our study. We found that the expression of PON3 was up-regulated in OSCC samples and cell lines. PON3 was associated with accelerating cell proliferation, cell cycle, migration and invasion in OSCC cells. Further research showed that PON3 was regulated by PI3K/Akt pathway. We also found that AP-1 was an important transcriptional factor regulating PON3 expression in OSCC. The study elucidates that PI3K/Akt pathway up-regulated the expression of PON3 in OSCC by AP-1. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:712 / 717
页数:6
相关论文
共 50 条
  • [21] Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway
    Ci, C.
    Wu, C.
    Lyu, D.
    Chang, X.
    He, C.
    Liu, W.
    Chen, L.
    Ding, W.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (02) : 194 - 201
  • [22] As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma
    Liu, Shanshan
    Gao, Wenzhen
    Lu, Yupu
    Zhou, Qin
    Su, Rongjian
    Hasegawa, Tomoka
    Du, Juan
    Li, Minqi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (02): : 491 - 506
  • [23] Targeting the PI3K/AKT/mTOR pathway in cutaneous squamous cell carcinoma
    Perry, Jay Ryan
    Thind, Amarinder Singh
    Minaei, Elahe
    Ryan, Emily
    Genenger, Benjamin
    Iyer, Gopal
    Martin, Carolan
    Ashford, Bruce
    Ranson, Andmarie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 43 - 43
  • [24] CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas
    Huang, Yi
    Xu, Jing
    Xu, Ying
    Li, Li
    Zheng, Min
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1486 - 1496
  • [25] Erufosine affects the PI3K/AKT/mTOR axis and induces apoptosis in oral squamous cell carcinoma
    Ansari, Shariq S.
    Ivanova, Elizabet
    Berger, Martin R.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S53 - S53
  • [26] Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma
    Xu, Haoyue
    Chen, Guanzheng
    Niu, Qifang
    Song, Kai
    Feng, Zhien
    Han, Zhengxue
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2022, 134 (05): : 599 - 614
  • [27] Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway
    Ma, Lei
    Huang, Ke
    Zhang, Haibo
    Kim, Eungyung
    Kim, Hyeonjin
    Liu, Zhibin
    Kim, Chae Yeon
    Park, Kanghyun
    Raza, Muhammad Atif
    Kim, Kirim
    Yi, Junkoo
    Sung, Yonghun
    Ryoo, Zae Young
    Kim, Yong-Gun
    Kim, Myoung Ok
    JOURNAL OF CANCER, 2024, 15 (03): : 659 - 670
  • [28] NUCKS1 promotes breast cancer cell proliferation and metastasis via PI3K/AKT pathway
    Li, Song
    Wang, Daoliang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (10) : 2099 - 2105
  • [29] JDHY3 Inhibits Hypopharyngeal Carcinoma Cell Proliferation and Promotes Apoptosis by Inhibiting the PI3K/AKT Pathway
    Dai, Weili
    Ni, Zhen
    Zhang, Ganlin
    Xu, Jia
    Qin, Xiaoyan
    Cao, Jingpeng
    Liu, Liangfa
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (11) : 1327 - 1335
  • [30] STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
    Yang, Shuwen
    Ji, Qinghai
    Chang, Bin
    Wang, Yan
    Zhu, Yongxue
    Li, Duanshu
    Huang, Caiping
    Wang, Yulong
    Sun, Guohua
    Zhang, Ling
    Guan, Qing
    Xiang, Jun
    Wei, Wenjun
    Lu, Zhongwu
    Liao, Tian
    Meng, Jiao
    Wang, Ziliang
    Ma, Ben
    Zhou, Li
    Wang, Yu
    Yang, Gong
    ONCOTARGET, 2017, 8 (04) : 5976 - 5991